IL245139B - Methods and pharmaceutical compositions of estradiol for vaginal insertion - Google Patents

Methods and pharmaceutical compositions of estradiol for vaginal insertion

Info

Publication number
IL245139B
IL245139B IL245139A IL24513916A IL245139B IL 245139 B IL245139 B IL 245139B IL 245139 A IL245139 A IL 245139A IL 24513916 A IL24513916 A IL 24513916A IL 245139 B IL245139 B IL 245139B
Authority
IL
Israel
Prior art keywords
methods
pharmaceutical compositions
vaginal
estradiol pharmaceutical
vaginal inserted
Prior art date
Application number
IL245139A
Other languages
English (en)
Hebrew (he)
Other versions
IL245139A0 (en
Inventor
Brian A Bernick
Janice Louise Cacace
Peter H R Persicaner
Julia M Amadio
Thorsteinn Thorsteinsson
Frederick D Sancilio
Irani Neda
Original Assignee
Therapeuticsmd Inc
Brian A Bernick
Janice Louise Cacace
Peter H R Persicaner
Julia M Amadio
Thorsteinn Thorsteinsson
Frederick D Sancilio
Irani Neda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/099,562 external-priority patent/US8987237B2/en
Priority claimed from PCT/US2014/061811 external-priority patent/WO2015073177A1/en
Application filed by Therapeuticsmd Inc, Brian A Bernick, Janice Louise Cacace, Peter H R Persicaner, Julia M Amadio, Thorsteinn Thorsteinsson, Frederick D Sancilio, Irani Neda filed Critical Therapeuticsmd Inc
Publication of IL245139A0 publication Critical patent/IL245139A0/en
Publication of IL245139B publication Critical patent/IL245139B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/02Suppositories; Bougies; Bases therefor; Ovules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • A61K9/4825Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4875Compounds of unknown constitution, e.g. material from plants or animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
IL245139A 2013-10-22 2016-04-14 Methods and pharmaceutical compositions of estradiol for vaginal insertion IL245139B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361894411P 2013-10-22 2013-10-22
US14/099,562 US8987237B2 (en) 2011-11-23 2013-12-06 Natural combination hormone replacement formulations and therapies
US201461932140P 2014-01-27 2014-01-27
PCT/US2014/061811 WO2015073177A1 (en) 2013-10-10 2014-10-22 Vaginal inserted estradiol pharmaceutical compositons and methods

Publications (2)

Publication Number Publication Date
IL245139A0 IL245139A0 (en) 2016-06-30
IL245139B true IL245139B (en) 2020-08-31

Family

ID=55697531

Family Applications (1)

Application Number Title Priority Date Filing Date
IL245139A IL245139B (en) 2013-10-22 2016-04-14 Methods and pharmaceutical compositions of estradiol for vaginal insertion

Country Status (8)

Country Link
EP (1) EP3060179A4 (ja)
JP (1) JP6680672B2 (ja)
KR (2) KR102335160B1 (ja)
AU (3) AU2014349132A1 (ja)
BR (1) BR112016009008B8 (ja)
IL (1) IL245139B (ja)
MX (1) MX2022002614A (ja)
RU (1) RU2713888C2 (ja)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739558B1 (fr) * 1995-10-05 1997-11-28 Innothera Lab Sa Forme galenique unitaire pour hormonotherapie locale de la secheresse vaginale
FR2759292B1 (fr) * 1997-02-10 2000-08-11 Cird Galderma Utilisation de retinoides en tant qu'agents induisant la pigmentation
EP1030629A4 (en) * 1997-11-03 2001-09-05 Deschutes Medical Products Inc PESSAR WITH A CARTRIDGE CONTAINING DRUGS
CA2293605A1 (en) * 1998-04-11 1999-10-21 Paolo Luca Maria Giorgetti Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
EP1441707A1 (en) * 2001-11-09 2004-08-04 Pharmacia AB Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
AU2003290071A1 (en) * 2002-12-18 2004-07-09 Ferrer Internacional, S.A. Pharmaceutical compositions of sertaconazole for vaginal use
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
BRPI0614625A2 (pt) * 2005-08-12 2011-04-12 Drugtech Corp composição farmacêutica que compreende pelo menos um composto estrogênico, sistema de distribuição de estrogênio vaginal, uso de uma composição e kit que compreende uma pluralidade de cremes vaginais
EP1872775A1 (en) * 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
PT2782584T (pt) * 2011-11-23 2021-09-02 Therapeuticsmd Inc Preparações e terapias de substituição para hormonoterapias naturais combinadas
WO2013112947A1 (en) * 2012-01-26 2013-08-01 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
WO2013130535A1 (en) * 2012-02-27 2013-09-06 Newgen Biopharma Corporation Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same

Also Published As

Publication number Publication date
RU2016118396A (ru) 2017-11-28
KR20210148435A (ko) 2021-12-07
BR112016009008B1 (pt) 2022-09-06
MX2022002614A (es) 2022-04-11
JP6680672B2 (ja) 2020-04-15
EP3060179A1 (en) 2016-08-31
JP2016534025A (ja) 2016-11-04
AU2014349132A1 (en) 2016-04-14
BR112016009008B8 (pt) 2023-01-31
RU2016118396A3 (ja) 2018-07-17
IL245139A0 (en) 2016-06-30
AU2014349132A8 (en) 2016-07-14
AU2021218231A1 (en) 2021-09-09
AU2019204658B2 (en) 2021-05-20
KR102488424B1 (ko) 2023-01-12
BR112016009008A2 (ja) 2017-08-01
KR20160062097A (ko) 2016-06-01
RU2713888C2 (ru) 2020-02-10
EP3060179A4 (en) 2017-05-17
KR102335160B1 (ko) 2021-12-03
AU2019204658A1 (en) 2019-07-18

Similar Documents

Publication Publication Date Title
IL273205A (en) Preparations and methods
HK1218560A1 (zh) 組成與方法
ZA201602510B (en) Strigolactone formulations and uses thereof
HK1223975A1 (zh) 含納米氣泡的組合物及其用途
GB2527241B (en) Compositions and methods
IL286759A (en) Therapeutic methods and preparations
EP2953474A4 (en) COMPOSITIONS AND METHODS
PL3013769T3 (pl) Zestaw ogniotrwały i jego zastosowanie
EP2815746A4 (en) SAPONIN NANOMIZELES, MANUFACTURING METHOD, APPLICATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF
GB201317286D0 (en) Composition and Use
GB201308072D0 (en) Compositions and methods
HK1220920A1 (zh) 治療性組合物和其用途
GB201305813D0 (en) Compositions and methods
IL246167A0 (en) Formulations of berberine and their uses
HK1219691A1 (zh) 醫藥組成物及其用途
EP2968698A4 (en) COMPOUNDS AND COMPOSITIONS FOR RELEASE OF MEDICAMENT
GB201318151D0 (en) Composition and device
IL259884A (en) Medicinal estradiol compositions for vaginal insertion and methods of using them
IL245139A0 (en) Methods and pharmaceutical compositions of estradiol for vaginal insertion
GB201319255D0 (en) Therapeutic compositions and methods
GB201322617D0 (en) Methods and compositions
GB201322467D0 (en) Composition and use
GB201312393D0 (en) Compositions and Methods

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed